The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParagon Group Regulatory News (PAG)

Share Price Information for Paragon Group (PAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 715.00
Bid: 699.00
Ask: 720.00
Change: 0.00 (0.00%)
Spread: 21.00 (3.004%)
Open: 715.00
High: 715.00
Low: 715.00
Prev. Close: 715.00
PAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Sep 2022 07:00

RNS Number : 8103X
Paragon Banking Group PLC
01 September 2022
 

Paragon Banking Group PLC ("Paragon" or the "Group")

Non-executive director appointment

Paragon is pleased to announce the appointment of Tanvi Davda as a Non-Executive Director and member of the Risk and Compliance and Remuneration Committees with effect from 1 September 2022.

Tanvi brings a diverse range of skills and knowledge to the Board. With an Executive career of more than 25 years she began her career at Credit Suisse as a Derivatives Trader, then went on to work with IBM as a Management Consultant before joining ABN AMRO and then Barclays Wealth where she was Managing Director of Global Research and Investments at Barclays Wealth.

In 2015, Tanvi co-founded Saranac Partners ("Saranac"), a boutique Wealth Manager, where she was CEO until 2021. She now serves on the Saranac board as a Non-Executive Director. 

Tanvi's non-executive career also included roles on the board of Ofqual, the qualifications and examinations regulator, and the Student Loans Company. 

Tanvi said: "I am very pleased to be joining Paragon as it continues on its journey to being the UK's leading technology-enabled specialist bank."

Robert East, Chair of the Board added: "Tanvi has exemplary finance, advisory and regulatory experience, which complements the existing skillset of the Board and will benefit the Group considerably."

This announcement is made in accordance with Rule 9.6.11 of the Listing Rules.

The Group confirms there are no matters requiring disclosure under Rule 9.6.13 of the Listing Rules.

For further information contact:

Marius van Niekerk, General Counsel and Company Secretary

Deborah Bateman, Director External Relations

Tel: 0121 712 2075

 

1 September 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGFRDMDGZZM
Date   Source Headline
29th Apr 20245:02 pmRNSTransaction in Own Shares
26th Apr 20244:50 pmRNSTransaction in Own Shares
25th Apr 20245:09 pmRNSTransaction in Own Shares
24th Apr 20244:59 pmRNSTransaction in Own Shares
23rd Apr 20244:55 pmRNSTransaction in Own Shares
22nd Apr 20244:55 pmRNSTransaction in Own Shares
19th Apr 20245:03 pmRNSTransaction in Own Shares
18th Apr 20245:04 pmRNSTransaction in Own Shares
18th Apr 20247:12 amRNSListing Rule 9.6.14(R) Disclosure
17th Apr 20245:02 pmRNSTransaction in Own Shares
16th Apr 20244:57 pmRNSTransaction in Own Shares
15th Apr 20244:57 pmRNSTransaction in Own Shares
12th Apr 20244:48 pmRNSTransaction in Own Shares
11th Apr 20245:03 pmRNSTransaction in Own Shares
10th Apr 20244:59 pmRNSTransaction in Own Shares
9th Apr 20245:01 pmRNSTransaction in Own Shares
8th Apr 20245:12 pmRNSTransaction in Own Shares
4th Apr 20245:01 pmRNSTransaction in Own Shares
3rd Apr 20245:10 pmRNSTransaction in Own Shares
2nd Apr 20245:20 pmRNSTransaction in Own Shares
2nd Apr 20249:14 amRNSTotal Voting Rights
28th Mar 20245:00 pmRNSTransaction in Own Shares
28th Mar 20242:37 pmRNSDirector/PDMR Shareholding
27th Mar 20245:06 pmRNSTransaction in Own Shares
26th Mar 20245:17 pmRNSTransaction in Own Shares
25th Mar 20245:05 pmRNSTransaction in Own Shares
22nd Mar 20244:51 pmRNSTransaction in Own Shares
21st Mar 20245:37 pmRNSTransaction in Own Shares
20th Mar 20245:07 pmRNSTransaction in Own Shares
20th Mar 20242:50 pmRNSHolding(s) in Company
20th Mar 20247:00 amRNSManagement of share buyback programme
19th Mar 20245:05 pmRNSTransaction in Own Shares
19th Mar 20242:19 pmRNSDirector/PDMR Shareholding
18th Mar 20244:49 pmRNSTransaction in Own Shares
15th Mar 20244:51 pmRNSTransaction in Own Shares
14th Mar 20245:11 pmRNSTransaction in Own Shares
14th Mar 202411:45 amRNSDirector/PDMR Shareholding
13th Mar 20245:13 pmRNSTransaction in Own Shares
12th Mar 20244:57 pmRNSTransaction in Own Shares
11th Mar 20245:18 pmRNSTransaction in Own Shares
11th Mar 202412:03 pmRNSDirector/PDMR Shareholding
8th Mar 20245:03 pmRNSTransaction in Own Shares
7th Mar 20244:54 pmRNSTransaction in Own Shares
6th Mar 20245:06 pmRNSTransaction in Own Shares
6th Mar 20241:48 pmRNSBoard Committee membership changes
6th Mar 20241:43 pmRNSResult of AGM
5th Mar 20245:01 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20244:56 pmRNSTransaction in Own Shares
29th Feb 20245:06 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.